In Hypertension (high blood pressure) Lacivas 4mg Tablet is a calcium channel blocker. It works by relaxing the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. Take regularly, as prescribed for this medicine to be most effective, even if you feel better.
Caution is advised when consuming alcohol with Lacivas 4mg Tablet. Please consult your doctor.
Lacivas 4mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Lacivas 4mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Lacivas 4mg Tablet may cause side effects which could affect your ability to drive.
Lacivas 4mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Lacivas 4mg Tablet may not be needed in these patients. Please consult your doctor.
Lacivas 4mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Lacivas 4mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Lacivas 4mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)